No connection

Search Results

DH vs HYPR

DH
Definitive Healthcare Corp.
NEUTRAL
Price
$1.07
Market Cap
$111.8M
Sector
Healthcare
AI Confidence
80%
HYPR
Hyperfine, Inc.
NEUTRAL
Price
$1.21
Market Cap
$119.2M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
DH
--
HYPR
--
Forward P/E
DH
5.74
HYPR
-3.67
P/B Ratio
DH
0.4
HYPR
2.87
P/S Ratio
DH
0.46
HYPR
8.79
EV/EBITDA
DH
5.67
HYPR
-2.33

Profitability

Gross Margin
DH
84.28%
HYPR
49.79%
Operating Margin
DH
-10.91%
HYPR
-144.87%
Profit Margin
DH
-57.52%
HYPR
-262.29%
ROE
DH
-40.42%
HYPR
-79.01%
ROA
DH
-1.41%
HYPR
-40.61%

Growth

Revenue Growth
DH
-1.2%
HYPR
128.0%
Earnings Growth
DH
--
HYPR
--

Financial Health

Debt/Equity
DH
0.46
HYPR
0.01
Current Ratio
DH
1.64
HYPR
4.34
Quick Ratio
DH
1.49
HYPR
3.56

Dividends

Dividend Yield
DH
--
HYPR
--
Payout Ratio
DH
0.0%
HYPR
0.0%

AI Verdict

DH NEUTRAL

DH shows neutral fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Mixed signals with both opportunities and risks present.

Strengths
Strong financial trend (Piotroski F-Score: 7/9)
Low debt with D/E ratio of 0.46
Risks
Low profit margin of -57.5%
Declining revenue (-1.2%)
Weak ROE of -40.4%
HYPR NEUTRAL

HYPR presents a high-risk, high-reward profile characterized by a stable Piotroski F-Score of 4/9 and a lack of traditional valuation benchmarks due to negative earnings. The company is experiencing explosive revenue growth (128% YoY) and maintains a strong liquidity position with a Current Ratio of 4.34 and negligible debt. However, these strengths are offset by severe profit margins (-262.29%) and a bearish insider sentiment. The stock is currently a speculative growth play where the market is pricing in future scalability rather than current fundamentals.

Strengths
Explosive revenue growth of 128% YoY
Strong liquidity with a Current Ratio of 4.34
Very low leverage (Debt/Equity of 0.01)
Risks
Severe negative profit margins (-262.29%)
Bearish insider activity with consistent selling by C-suite executives
High valuation relative to sales (P/S of 8.79) for a non-profitable firm

Compare Another Pair

DH vs HYPR: Head-to-Head Comparison

This page compares Definitive Healthcare Corp. (DH) and Hyperfine, Inc. (HYPR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile